Articles

• The Transformative Role of Artificial Intelligence in Diabetes Treatment

  Masoud Rostami, Vida Sadat Anoosheh

  • PDF
• A Comparison of Renal Effects between Empagliflozin and Linagliptin in Diabetic Patients with Chronic Kidney Disease: A Randomized Clinical Trial

  Reza Zeinabadi Noghabi, Rojin Rouintan, Tahereh Sabaghian, Shayesteh Khalili

  • PDF
• Predictors of Mortality among Intensive Care Unit (ICU) Hospitalized Diabetic Patients with COVID-19

  Mohsen Gholinataj Jelodar, Samaneh Mirzaei, Majid Haji Maghsoudi

  • PDF
• Identifying Barriers to the Participation of Diabetic Patients in Khuzestan Province in Sports Activities

  Asadollah Pirayesh, Sedighe Heydarinejad, Esmaeel Veisia

  • PDF
• Effects of Lipoic Acid and High-Intensity Interval Training (HIIT) on Pancreatic VEGFR-3 Levels in Diabetic Rat Model

  Seyed Ramin Hashemian Esfahani, Minoo Dadban Shahamat, Asra Askari, Abbas Nezhadebrahimi

  • PDF
• Antibody Engineering to Enhancement of Ranibizumab Binding Affinity for the Prevention and Treatment of Diabetic Retinopathy

  Fateme Sefid, Kimia Monshizadeh, Ghasem Azamirad, Mohammad Yahya Vahidi Mehrjardi

  • PDF
• Vildagliptin-Associated Bullous Pemphigoid: A Case Report

  Debanjan Roy, Gunjan Gayen, Sabnam Ara Begum, Sandip Ghosh, Sucheto Talukder, Arisha Sarkar, Shritama Aich

  • PDF
• Genetic and Epigenetic Etiologies of Type 1 Diabetes Mellitus

  Tajudeen Yahaya, Israel Obaroh, Umar Magaji, Caleb Obadiah, Daniel Anyebe, Ufuoma Shemishere

  • PDF